Heerspink Hiddo J. L. and Cherney David and Kollaborációs szerevezet: DAPA-CKD Trial Committees and Investigators and Wittmann I. and Vörös P. and Dudás M. and Tabak G. A. and Kirschner R. and Letoha Annamária and Balku I. and Hermanyi Z. and Zakar G. and Mezei I. and Nagy G. G. and Lippai J. and Németh A.:
A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function.
KIDNEY INTERNATIONAL, 101 (1).
pp. 174-184.
ISSN 0085-2538
(2021)
Preview |
Text
HeerspinkKidneyInt2021.pdf - Accepted Version Download (729kB) | Preview |
Creators: |
|
||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Item Type: | Journal Article | ||||||||||||||||
Szerzők száma: | 430 | ||||||||||||||||
Journal or Publication Title: | KIDNEY INTERNATIONAL | ||||||||||||||||
Date: | 2021 | ||||||||||||||||
Volume: | 101 | ||||||||||||||||
Number: | 1 | ||||||||||||||||
Page Range: | pp. 174-184 | ||||||||||||||||
ISSN: | 0085-2538 | ||||||||||||||||
Faculty/Unit: | Albert Szent-Györgyi Medical School | ||||||||||||||||
Institution: | University of Szeged (2000-) | ||||||||||||||||
Language: | English | ||||||||||||||||
MTMT rekordazonosító: | 32539647 | ||||||||||||||||
DOI azonosító: | https://doi.org/10.1016/j.kint.2021.09.005 | ||||||||||||||||
Date Deposited: | 2021. Dec. 16. 08:47 | ||||||||||||||||
Last Modified: | 2022. Mar. 07. 12:37 | ||||||||||||||||
URI: | http://publicatio.bibl.u-szeged.hu/id/eprint/23067 |
Web of Science® Times Cited: 60 | View citing articles in Web of Science® |
Actions (login required)
![]() |
View Item |